Company intelligence / Profile preview
Hexagon Bio
Menlo Park, California, United Stateshexagonbio.com ↗
- Ownership
- Private
- Employees
- ~82
- Development stage
- Preclinical
01
Overview
Hexagon Bio is developing novel ADC payloads with mechanisms orthogonal to existing payload mechanisms for treating cancer patients with unmet needs. The company is advancing candidates toward development nomination.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small moleculesAntibody Drug Conjugate (ADC) payloads
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Beyond the preview
Go deeper on Hexagon Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hexagon Bio.